Terns Pharmaceuticals, Inc. logo TERN - Terns Pharmaceuticals, Inc.

NEXT EARNINGS: Mar 19, 2026 (in 22 days) EPS Est: $-0.30
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 14
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $55.67 DETAILS
HIGH: $70.00
LOW: $35.00
MEDIAN: $56.00
CONSENSUS: $55.67
UPSIDE: 34.31%
Market Cap: 3.73B
Volume: 1,256,725
Avg Volume: 3,034,316
52 Week Range: 1.865-48.26
Sector: Healthcare
Industry: Biotechnology
Beta: -0.28
Last Dividend: $N/A
Exchange: NASDAQ
Country: US
Employees: 59
IPO Date: 2021-02-05
EPS (TTM): -1.12
P/E Ratio: -4.96
Revenue (TTM): N/A
Total Assets: 363.93M
Total Debt: 1.35M
Cash & Equiv: 161.44M
Rev Growth (5Y): N/A
EPS Growth (5Y): N/A
FCF Growth (5Y): N/A
ROCE: -29.2%
Debt/Equity: 0.00

Earnings History

Date EPS Actual EPS Est EPS Surprise Rev Actual Rev Est Rev Surprise
2025-11-10 $-0.27 $-0.30 +10.0%
2025-08-05 $-0.26 $-0.28 +7.1%
2025-05-08 $-0.26 $-0.29 +10.3%
2025-03-20 $-0.24 $-0.30 +20.0%
2024-11-12 $-0.28 $-0.33 +15.2%
2024-08-05 $-0.31 $-0.35 +11.4%
2024-05-13 $-0.30 $-0.36 +16.7%
2024-03-14 $-0.29 $-0.29 0.0% $1.3M

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019 2018
Revenue 0 0 0 1.00M 0 0 0
Net Income (88.85M) (90.21M) (60.34M) (50.16M) (29.35M) (68.82M) (17.71M)
EPS -1.12 -1.27 -1.67 -1.98 -1.61 -2.74 -0.74
Total Assets 363.93M 268.52M 287.03M 168.07M 92.29M 23.90M 89.07M
Total Debt 1.35M 603,000 1.21M 0 12.88M 0 0
Cash & Equivalents 161.44M 79.93M 143.24M 47.70M 74.85M 12.33M 82.52M
Operating Cash Flow (70.02M) (67.39M) (49.11M) (41.83M) (29.81M) (66.22M) (18.07M)
Free Cash Flow (70.06M) (67.44M) (49.38M) (42.17M) (30.39M) (67.12M) (18.32M)
FCF per Share -0.88 -0.95 -1.37 -1.67 -1.21 -2.67 -0.76
Book Value 345.87M 255.37M 276.94M 160.30M 68.59M 4.21M 72.23M
Cash & ST Investments 358.16M 263.44M 283.11M 165.98M 74.85M 19.65M 86.88M
ROC Equity -0.26 -0.35 -0.22 -0.31 -0.43 -16.36 -0.25